Navigation Links
HRR 4th Edition Test with Spanish and English Instructions

ProductsHRR 4th Edition Test with Spanish and English Instructions
Company Richmond Products, Inc.
Item HRR 4th Edition Test with Spanish and English Instructions
Features 
Description HRR 4th edition pseudoisochromatic test from Richmond Products includes the four demonstration plates, the six screener plates and the 14 diagnostic series for a total of 24 plates. Each of these plates has its own tab for easy and clean page selection. The test also includes a set of instructions in English and a laminated copy of the score sheet. The score sheet can then be copied directly onto the patients record or copies can be made locally. A pad of score sheets is available separately. The structure of the test in terms of sequence and plate layout is identical to the original HRR published by American optical. The only real difference is in the quality of the printing which has been improved by the use of the latest in genetic understanding and printing technology.
Info Richmond Products, Inc.Call Richmond Products, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-435-4770

Customer Service: 505-275-2406
Web site: http://www.richmondproducts.com

Related medicine products :

1. HRR 4th Edition Pseudoisochromatic Test - English Instruction Version
2. MiniSpin plus Special Limited Edition Personal Micro Centrifuge
3. Harrisons Manual of Medicine, 15th Edition
4. Essentials of Diagnosis and Treatment 2nd Edition for PDA
5. Daviss Drug Guide for Nurses, 9th Edition for PDA
6. Schwartz Principles of Surgery PDA Edition
7. 2005 Edition of Geriatrics At Your Fingertips (PDA Version)
8. AcerMed EMR Cardiology Edition
9. AcerMed EMR Orthopaedics Edition
10. Signature Edition GOLD Infusion System
11. A to Z Drug Facts, 6th Edition
Woodson Elevator
Henner Elevator
Tenzel Double-Ended Periosteal Elevator
DesMarres Lid Retractor
Medicine Products:
(Date:12/2/2009)...2 Holly Potter, vice president, Pu...agement for Kaiser Permanente, received the "PR Te...held at the National Press Club. ,, PR News,...nnovators and professionals who day in and day out...ce. The winners of this year,s program set the ben...
(Date:12/2/2009)...., Dec. 2 From more than 1,100 pho...ning, joy and peace, the LIFE Foundation has selec...d using the popular photo-sharing Web site flickr....ontage on the LIFE Foundation,s Web site at www.l...submitted one photo and a caption to Flickr.com du...
(Date:12/2/2009)...c. 2 US Farms, Inc. (Pin..., Nursery and Wellness products, is pleased to ann...ts at the Cook,sware A,faire in Oakland, Calif., a...or additional information, contact US Farms, Inc. ...it http://cookswareafaire.com ,, Victor Brand...
(Date:12/2/2009)...., Dec. 2 Watson Pharmac... the Federal Trade Commission (FTC) has accepted a...g to Watson,s pending acquisition of privately hel... the Hart Scott Rodino waiting period, thereby per... parties have now obtained all regulatory approval...
(Date:12/2/2009)...Red Cross also part of the Hewlett-Packard Company...2 The Hewlett-Packard C...lion this year to help fund American Red Cross dis...com/cgi-bin/prnh/20090108/RedCrossLOGO ) ,, Th...p Philippine communities affected by typhoons in S...
Breaking Medicine News(10 mins):Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 3Health News:Wonders of Life Photo Contest Winners Announced 2Health News:Wonders of Life Photo Contest Winners Announced 3Health News:US Farms, Inc. Showcasing Aloe365(TM) Product Line at Cook'sware A'faire at Oakland Zoo 2Health News:Watson Receives FTC Clearance for Arrow Acquisition 2Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 2Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 3
... exercisers. A new study in older adults finds tha...process by as much as 25 percent//. The faster...e infected. The results appear in a recent iss...ding to Charles Emery, a professor of psychology a...
... this may be due to genetic factors, according to ...ychiatry.// In the January issue of the journal, r...ession is higher in women than in men, where it is...depression in twins done to date. In addition, it ...
Only 75 per cent of Australian children eligible for free booster vaccine against pneumococcal disease got their shots before the program finished at the end of 2005, government figures show//. Th
...he hunting and killing of any wild birds. Turkish ...that the prohibition would continue// till Turkey ...he Eastern part of Turkey has seen two deaths due ...sis period. Agriculture and Rural Affairs Mini...
...here is a fear instilled by the disease among the ...h. But now scientist hopes that the disease can be...ermining the genes responsible to fight the diseas...ch done by the Universities of Oxford, KwaZulu-Nat...
...t and mortality rates through the launch of its ne... 72,000 babies die every year during delivery in t...iranjeevi, the government aims to bring the matern...nd births. The infant mortality rate at present is...
Other Medicine News:Health News:Wounds Heal 25% Faster In Older Adults Who Exercise Regularly 2Health News:Wounds Heal 25% Faster In Older Adults Who Exercise Regularly 3
(Date:12/2/2009)...ecember 2 Cardio Vascula...per of advanced,cardiovascular surgery technology,...tors approved a one-for-three forward stock split,...o Vascular Medical Device shareholders. , ...ated date the stock,split will be payable and the ...
(Date:12/2/2009)...2 Roche (SIX: RO, ROG; O...s Food & Drug Administration (FDA) approved an...acid test, to screen source plasma in pools compri...lled the cobas® TaqScreen MPX Test for use on...tro test for the simultaneous, direct detection of...
(Date:12/2/2009)...., Dec. 2 Novartis announced today...tion on Tasigna® (nilotinib) 200 mg capsules ... the strength of the company,s hematology portfoli...w data, at the 51st American Society of Hematology...e company,s current therapies and investigational ...
Breaking Medicine Technology:Cardio Vascular Medical Device Announces Forward Stock Split 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25American Medical Informatics Association 28AMIA 29 Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certifi 13045 1American Medical Informatics Association 28AMIA 29 Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certifi 13045 2National Coalition of Mental Health Consumer Survivor Organizations Hires Director of Government Relations 51792 1National Coalition of Mental Health Consumer Survivor Organizations Hires Director of Government Relations 51792 2Proposed Water Trust Fund Bill Would Provide Solid Foundation for Improvement 51788 1Proposed Water Trust Fund Bill Would Provide Solid Foundation for Improvement 51788 2